Try our Advanced Search for more refined results

Expert Analysis

How Fed. Circ. Is Applying Section 101 To Drug Patents

By Mark Waddell, Ryan Hagglund and Dan Liu (May 12, 2023, 6:25 PM EDT) -- Between 2010 and 2014, the U.S. Supreme Court issued four decisions on patent subject matter eligibility under Title 35 of the U.S. Code, Section 101 —  Bilski v. Kappos,[1] Mayo Collaborative Services v. Prometheus Labs Inc.,[2] Association for Molecular Pathology v. Myriad Genetics Inc.[3] and Alice Corp v. CLS Bank International[4] — establishing its modern Section 101 jurisprudence....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!